Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Abbvie Inc (ABBV)

2014-11-27@05:35:37 ET
Form 4: Update Filing for AbbVie Inc (ABBV) (VKR)

2014-11-27@05:35:25 ET
Form 4: Update Filing for AbbVie Inc (ABBV) (VKR)

2014-11-27@05:35:15 ET
Form 4: Update Filing for AbbVie Inc (ABBV) (VKR)

2014-11-26@22:13:07 ET
AbbVie Reports Third-Quarter 2014 Financial Results (EUR)

2014-11-26@18:34:22 ET
AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year (EUR)

2014-11-26@17:00:55 ET
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend (EUR)

2014-11-26@17:00:13 ET
Announcement Of Termination Of Proposed AbbVie And Shire Transaction (EUR)

2014-11-26@16:00:00 ET
Gardy & Notis LLP Issues Notice Of The Filing Of A Securities Class Action Against AbbVie And Its Chief Executive Officer (PRN)

2014-11-26@15:16:39 ET
AbbVie Board Recommends Stockholders Vote Against Shire Transaction (EUR)

2014-11-26@14:32:52 ET
Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider Recommendation (EUR)

2014-11-26@13:34:19 ET
AbbVie Announces Late-Breaking Results from Phase 3 Trial of HUMIRA(R) (adalimumab) in Hidradenitis Suppurativa (HS) Patients at the European Academy of Dermatology and Venereology Congress (EUR)

2014-11-25@07:10:34 ET
Novo Nordisk's Victoza Recommended for Label Expansion (ZAX)

2014-11-21@15:13:34 ET
AbbVie acquires manufacturing facility in Tuas Biomedical Park, Singapore (DTF)

2014-11-21@08:00:00 ET
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX(TM) (ombitasvir/paritaprevir/ritonavir) + EXVIERA(TM) (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe (PRN)

2014-11-19@20:33:05 ET
Rheumatoid Arthritis Therapeutics Clinical Trials Market by Region, Companies, Trial Status, Phase H2 2014 (PRW)

2014-11-19@05:22:20 ET
AbbVie announces favorable results from Phase IIb hepatitis C study (DTM)

2014-11-19@05:17:16 ET
AbbVie announces encouraging results from Phase I glioblastoma multiforme trial (DTM)

2014-11-17@07:00:00 ET
AbbVie to Present at Jefferies 2014 Global Healthcare Conference (PRN)

2014-11-17@05:16:38 ET
Myriad signs expanded companion diagnostic agreement with AbbVie (DTM)

2014-11-14@20:36:54 ET
AbbVie Inc.Corporate Event Announcement Notice (WSH)